Analysis of the United States Molecular Imaging Equipment and Radiopharmaceuticals Market, Forecast to 2023

  • ID: 4200713
  • Report
  • Region: United States
  • 167 Pages
  • Frost & Sullivan
1 of 4
Technology Advances and New Radiopharmaceuticals Maintain the Industry on a Growth Track

FEATURED COMPANIES

  • Bio-Nucleonics
  • Eckert & Ziegler Nuclitec
  • Jubilant Draximage
  • Mayo Clinic
  • NeuSoft
  • Piramal
  • MORE

Molecular imaging can easily be described as the next frontier of medical imaging. In an era of value-based reimbursement, molecular imaging is set to play a significant role in quicker diagnosis, more accurate disease staging, and selection of targeted treatments. Launch of new radiopharmaceuticals across clinical areas other than cardiology and oncology such as neurology and orthopedics is also expected to drive greater adoption of molecular imaging as part of clinical care pathways.

However, molecular imaging continues to face several challenges, notably the high cost of molecular imaging modalities and image scans, competition from lower cost modalities such as CT and MRI, and concerns over future supply of Tc-99m, a key SPECT radiopharmaceutical used for cardiac scans. This study analyzes existing trends in the hybrid molecular imaging and diagnostic radiopharmaceuticals markets with an emphasis on understanding strategies employed by market participants to address these myriad challenges. It also assesses both these markets in the context of changing regulatory and reimbursement policies in order to provide future market trends. This analysis will be critical in helping market participants create long-term viable strategies in order to remain competitive and ensure continuous innovation.

This deliverable assesses future trends in molecular imaging equipment revenues as well as growth in the number of unit shipments over the next few years. This will provide value to market participants that design and manufacture molecular imaging equipment. Market participants will also be provided insights on recent industry and technology trends that are shaping the molecular imaging market. Radiopharmaceutical manufacturers will be provided with key insights on the evolving usage trends of workhorse FDG and Tc-99m radiopharmaceuticals and the increasing adoption of new radiopharmaceuticals across new clinical areas. Companies that are in the process of developing software to improve quantitation accuracy, lower dosages, and reduce scan times for both PET and SPECT will be provided with key insights on how the molecular imaging market is growing as well as the factors that are required to facilitate greater adoption of PET and SPECT technologies.

READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Bio-Nucleonics
  • Eckert & Ziegler Nuclitec
  • Jubilant Draximage
  • Mayo Clinic
  • NeuSoft
  • Piramal
  • MORE
1. Research Methodology
Research Methodology
Scope of This Study

2. Executive Summary-Molecular Imaging
Key Findings
Measurements-PET/CT
Measurements-SPECT/CT
Measurements-PET/MR

3. Executive Summary-Radiopharmaceuticals
Key Findings
Measurements-PET
Measurements-SPECT

4. Market Overview
Scope of the Study-Molecular Imaging
Scope of the Study-Radiopharmaceuticals
Molecular Imaging-Segmentation
Molecular Imaging-Definition
Shift in Focus from Standalone to Hybrid Imaging
Radiopharmaceuticals-Definitions
Segmentation of Radiopharmaceuticals
Distribution of Radiopharmaceuticals
US Radiopharmacy Facility Landscape 2016

5. Drivers and Restraints-Total Molecular Imaging Equipment Market
Market Drivers
Improvements in Quantitation Accuracy
Role of Molecular Imaging in Personalized Medicine
Molecular Imaging Entering Into New Therapeutic Areas
Market Restraints
Affordability of Hybrid Modalities Will Remain Key Issue
Consolidations of Healthcare Providers
Changing Hospital Procurement Models

6. PET/CT Equipment Segment
Measurements
Unit Shipment Forecast
Revenue Forecast
Trend Analysis
Market Share
Market Share Analysis

7. SPECT/CT Equipment Segment
Measurements
Unit Shipment Forecast
Revenue Forecast
Trend Analysis
Market Share
Market Share Analysis

8. PET/MR Equipment Segment
Measurements
Unit Shipment Forecast
Revenue Forecast
Trend Analysis
Market Share
Market Share Analysis

9. Key Products and Participants
Analysis of Hybrid Molecular Imaging Products
Actively Marketed PET/CT Products in 2016
Actively Marketed PET/MR Products in 2016
Actively Marketed SPECT/CT Products in 2016

10. Latest Trends Among the Big Three Competitors-Philips Healthcare
Digital PET-The Next Chapter in Nuclear Imaging

11. GE Healthcare
GE Healthcare-Key Technology Trends
GE Debuts DiscoveryTM MI PET/CT at SNMMI 2016
Launch of Discovery IQ PET/CT by GE
GE Launches First General Purpose Digital SPECT/CT

12. Siemens Healthineers
Siemens Debuts Mobile Biograph Horizon PET/CT
Siemens Debuts Latest Version of syngo.via

13. Companies to Look Out For
NeuSoft
Toshiba America Medical Systems
Molecular Dynamics
UltraSPECT

14. Other Issues Impacting Growth Of Molecular Imaging
Upgradeability and Intra Modality Competition
Nuclear Medicine Physicians Face Employment Challenges

15. Key Technology and Industry Trends
Technology Trends-PET/CT & SPECT/CT
Industry Trends-Advancements in Brain Imaging Using SPECT
Industry Trends-PET Scanning and Alzheimer’s Disease
Industry Trends-CMS Approves Funding for PET Amyloid Study
Industry Trends-Myocardial Perfusion Imaging: PET vs. SPECT

16. Drivers and Restraints-Total Radiopharmaceuticals Market
Market Drivers
Development of New Radiopharmaceuticals
Adopting a Cyclotron-based Approach
Mo-99 Production-Key Challenges and Potential Solutions
Market Restraints
Pricing and Reimbursement of Tc-99m-Key Challenges
High Entry Barriers Limit the Number of Participants

17. PET Radiopharmaceuticals Segment
Measurements
Procedure Forecast
Revenue Forecast
Trend Analysis
Market Share
Market Share Analysis

18. SPECT Radiopharmaceuticals Segment
Measurements
Procedure Forecast
Revenue Forecast
Trend Analysis
Market Share
Market Share Analysis

19. Key Products and Participants
Analysis of PET and SPECT Radiopharmaceuticals
Key Market Participants and Main Product Lines

20. Key Companies to Look Out For
Siemens PETNET
IBA Molecular
Ionetix

21. Key Industry Trends
Jubilant Draximage Develops Rubidium Generator
Northstar Medical Isotopes to Produce Mo-99
FDA Approves Gallium 68 Dotatate Kit-NETSPOT
FDA Approves Axumin PET Radiopharmaceutical
Axumin-Safety and Efficacy Parameters
CMS Rejection of NaF-18 PET Scan Reimbursement
Cardiac PET Perfusion Agents Industry-A Snapshot

22. Role of New Radiopharmaceuticals in Oncology
Role of Radiopharmaceuticals in Oncology Clinical Trials
18F-CFA-The Next Frontier in Cancer Treatment
New PET Tracers for Clinical Use in Oncology

23. The Last Word
The Last Word-3 Big Predictions: Molecular Imaging
The Last Word-3 Big Predictions: Radiopharmaceuticals
Legal Disclaimer

24. Appendix
Glossary of Terms-Molecular Imaging
Glossary of Terms-Radiopharmaceuticals
Methodology

25. Medicare Hospital Outpatient Prospective Payment System (HOPPS)
Reimbursement of Procedures Involving Use of Radiopharmaceuticals and Molecular Imaging Modalities
Reimbursed Radiopharmaceuticals Billing Codes
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Advanced Accelerator Applications
  • Bio-Nucleonics
  • Blue Earth
  • Bracco
  • Cardinal
  • Eckert & Ziegler Nuclitec
  • Eli Lilly
  • GE
  • IBA Molecular
  • Jubilant Draximage
  • Kimberley-clark
  • Lantheus
  • MDS Nordion
  • Mallinckrodt
  • Mayo Clinic
  • Molecular Dynamics
  • Navidea
  • NeuSoft
  • PETNET
  • Pharmalucence
  • Philips
  • Piramal
  • Siemens Healthineers
  • Spectrum
  • Toshiba
  • UltraSPECT
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll